| Name | Toripalimab |
|---|---|
| Synonyms |
ade Toripalimab
ade Toripalimab(DHH02208) Toripalimab (anti-PD-1) |
| Description | Toripalimab is the first domestic anti-tumor PD-1 antibody in China. Toripalimab is a selective, recombinant, humanized monoclonal antibody against PD-1. Toripalimab is able to bind to PD-1 and block the interaction with its ligands. Toripalimab has exhibited primary anti-tumor effects in tumors such as melanoma, lung cancer, digestive tract tumors, hepatobiliary and pancreatic tumors, neuroendocrine neoplasms, nasopharyngeal carcinoma and urothelial carcinoma[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |